La Thangue NB - Search Results

1

The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age.

McLaughlin F, Finn P, La Thangue NB. McLaughlin F, et al. Among authors: la thangue nb. Drug Discov Today. 2003 Sep 1;8(17):793-802. doi: 10.1016/s1359-6446(03)02792-2. Drug Discov Today. 2003. PMID: 12946642 Review.

2

Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Plumb JA, Finn PW, Williams RJ, Bandara MJ, Romero MR, Watkins CJ, La Thangue NB, Brown R. Plumb JA, et al. Among authors: la thangue nb. Mol Cancer Ther. 2003 Aug;2(8):721-8. Mol Cancer Ther. 2003. PMID: 12939461

3

Histone deacetylase inhibitors in psoriasis therapy.

McLaughlin F, La Thangue NB. McLaughlin F, et al. Among authors: la thangue nb. Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):213-9. doi: 10.2174/1568010043343859. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15180476 Review.

4

Histone deacetylase inhibitors open new doors in cancer therapy.

McLaughlin F, La Thangue NB. McLaughlin F, et al. Among authors: la thangue nb. Biochem Pharmacol. 2004 Sep 15;68(6):1139-44. doi: 10.1016/j.bcp.2004.05.034. Biochem Pharmacol. 2004. PMID: 15313411 Review.

5

Chromatin control and cancer-drug discovery: realizing the promise.

Inche AG, La Thangue NB. Inche AG, et al. Among authors: la thangue nb. Drug Discov Today. 2006 Feb;11(3-4):97-109. doi: 10.1016/S1359-6446(05)03691-3. Drug Discov Today. 2006. PMID: 16533707 Review.

6

Histone deacetylase inhibitors: gathering pace.

Carey N, La Thangue NB. Carey N, et al. Among authors: la thangue nb. Curr Opin Pharmacol. 2006 Aug;6(4):369-75. doi: 10.1016/j.coph.2006.03.010. Epub 2006 Jun 14. Curr Opin Pharmacol. 2006. PMID: 16781195 Review.

7

Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor.

Bandara LR, Girling R, La Thangue NB. Bandara LR, et al. Among authors: la thangue nb. Nat Biotechnol. 1997 Sep;15(9):896-901. doi: 10.1038/nbt0997-896. Nat Biotechnol. 1997. PMID: 9306407

8

Histone deacetylase inhibitors and cancer therapy.

La Thangue NB. La Thangue NB. J Chemother. 2004 Nov;16 Suppl 4:64-7. doi: 10.1179/joc.2004.16.Supplement-1.64. J Chemother. 2004. PMID: 15688613 Review.

9

Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas.

Khan O, La Thangue NB. Khan O, et al. Among authors: la thangue nb. Nat Clin Pract Oncol. 2008 Dec;5(12):714-26. doi: 10.1038/ncponc1238. Epub 2008 Oct 7. Nat Clin Pract Oncol. 2008. PMID: 18839006 Review.

10

HDAC inhibitor-based therapies and haematological malignancy.

Stimson L, Wood V, Khan O, Fotheringham S, La Thangue NB. Stimson L, et al. Among authors: la thangue nb. Ann Oncol. 2009 Aug;20(8):1293-302. doi: 10.1093/annonc/mdn792. Epub 2009 Jun 10. Ann Oncol. 2009. PMID: 19515748 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters